Article info
PDFClinical ethics
Interactions of doctors with the pharmaceutical industry
- Correspondence to: M A Morgan Research Department, American College of Obstetricians and Gynecologists, 409 12th Street, SW, Washington, DC 20024, USA; mmorgan{at}acog.org
Citation
Interactions of doctors with the pharmaceutical industry
Publication history
- Received September 16, 2005
- Accepted January 5, 2006
- Revised December 21, 2005
- First published September 29, 2006.
Online issue publication
February 23, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by the Journal of Medical Ethics
Other content recommended for you
- Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study
- Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
- Physicians’ intent to comply with the American Medical Association’s guidelines on gifts from the pharmaceutical industry
- Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review
- Receipt and use of prohibited free samples of tobacco products among US adults who use cigarettes, cigars and smokeless tobacco, 2020
- Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians
- General practitioners and pharmaceutical sales representatives: quality improvement research
- Coming soon to a state near you?
- US doctors display “No drug reps” signs
- Open access to industry's clinically relevant data